Corporate News – Clinplus
Clinplus (ticker 301257.SZ) closed the trading session on Wednesday, 21 October 2026 at 10:20 AM Central Europe unchanged, with a 0 % change over the preceding 24 hours. The current share price on major exchanges is approximately CNY 34.17.
The total outstanding shares amount to 80.9 million. With a market capitalization of CNY 2.7 billion, Clinplus saw a trading volume of CNY 136.4 million during the last 24 hours. Compared with the close of the previous month, the stock has declined by 20.63 %. The simple moving average over the last 200 days is CNY 43.72. Over the past 52 weeks, Clinplus’ highest price reached CNY 85 on 14 January 2026, while the lowest price was CNY 31.52 on 19 October 2026.
Recent Corporate Development
Clinplus has announced progress in its obesity treatment programme. The company reported that a post‑trial data analysis of roughly 2,300 overweight or obese women demonstrated a significant reduction in body weight after 68 weeks of treatment. The effect was more pronounced in pre‑menopausal, peri‑menopausal and post‑menopausal subgroups. Waist‑circumference measurements indicated corresponding abdominal fat loss. Clinplus highlighted that these results build on earlier findings in a mixed‑gender cohort, where overall weight loss was slightly lower. The company plans a broader market launch of the drug within the next year and will continue to monitor additional studies to confirm these preliminary outcomes.
Comparative Stock Performance (Last 24 Hours)
| Stock | Ticker | 24‑hour Change | Current Price (CNY) | Market Capitalisation (CNY) |
|---|---|---|---|---|
| Liaoning Shenhua | 600653.SS | 0 % | 1.61 | 3.2 billion |
| Beijing Comens New Materia | 300200.SZ | 0 % | 7.78 | 3.2 billion |
| Huayan | 301138.SZ | 0 % | 26.52 | 3.2 billion |
| Daqian Ecology & Environment | 603955.SS | 0 % | 24.35 | 3.2 billion |
| Shenzhen Chuangyitong Tech | 300991.SZ | 0 % | 22.50 | 3.2 billion |
Additional valuation metrics are available for Beijing Comens New Materia (price‑to‑earnings ratio 38.76) and Huayan (price‑to‑earnings ratio 32.17).
